Chemours Co (CC) - Total Liabilities

Latest as of September 2025: $7.27 Billion USD

Based on the latest financial reports, Chemours Co (CC) has total liabilities worth $7.27 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Chemours Co - Total Liabilities Trend (2012–2024)

This chart illustrates how Chemours Co's total liabilities have evolved over time, based on quarterly financial data. See Chemours Co current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Chemours Co Competitors by Total Liabilities

The table below lists competitors of Chemours Co ranked by their total liabilities.

Company Country Total Liabilities
Sigma Advanced Systems Limited
NSE:MEGASOFT
India Rs242.03 Million
Tasly Pharmaceutical Group Co Ltd
SHG:600535
China CN¥2.79 Billion
Wingtech Technology Co Ltd
SHG:600745
China CN¥16.09 Billion
Sany Heavy Equipment International Holdings Company Limited
F:YXS
Germany €31.75 Billion
Aneka Tambang (Persero) TBK (PT)
AU:ATM
Australia AU$22.96 Trillion
Bucher Industries AG
SW:BUCN
Switzerland CHF919.40 Million
Seabridge Gold Inc.
TO:SEA
Canada CA$650.17 Million
Beijing Shiji Information Technology Co Ltd
SHE:002153
China CN¥1.46 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Chemours Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Chemours Co.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.33 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 24.40 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.96 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chemours Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chemours Co (2012–2024)

The table below shows the annual total liabilities of Chemours Co from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 $6.91 Billion -8.01%
2023-12-31 $7.51 Billion +14.99%
2022-12-31 $6.53 Billion +1.00%
2021-12-31 $6.47 Billion +3.21%
2020-12-31 $6.27 Billion -4.51%
2019-12-31 $6.56 Billion +3.48%
2018-12-31 $6.34 Billion -1.34%
2017-12-31 $6.43 Billion +7.92%
2016-12-31 $5.96 Billion -3.44%
2015-12-31 $6.17 Billion +167.59%
2014-12-31 $2.31 Billion -1.58%
2013-12-31 $2.34 Billion +12.16%
2012-12-31 $2.09 Billion --

About Chemours Co

NYSE:CC USA Specialty Chemicals
Market Cap
$3.26 Billion
Market Cap Rank
#4934 Global
#1619 in USA
Share Price
$21.77
Change (1 day)
-1.14%
52-Week Range
$10.48 - $27.94
All Time High
$43.52
About

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, … Read more